Abiomed Inc - Company Profile
Powered by 
All the sales intelligence you need on Abiomed Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Abiomed Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Abiomed Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Abiomed Inc (Abiomed) is a medical device company. It develops innovative heart pump technologies, including the Impella family, which provides temporary hemodynamic support for patients with severe coronary artery disease and heart failure. The company’s product portfolio includes the Impella CP, designed for high-risk PCI procedures and cardiogenic shock, and the Impella 5.5, offering full cardiac support for long-duration use. The Impella RP supports patients with right heart failure. Abiomed offers the Breethe OXY-1 System, a compact cardiopulmonary support device that oxygenates and pumps blood while enabling patient mobility. The company also offers Impella Connect, a cloud-based platform that allows healthcare teams to remotely monitor patient status. Abiomed is headquartered in Danvers, Massachusetts, the US.
Abiomed Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Impella CP | Impella Connect | Abiomed |
| Impella 5.5 | Impella | |
| Impella RP | ||
| XYZ | ||
| XYZ | ||
| XYZ |
Competitor Comparison
| Key Parameters | Abiomed Inc | Abbott Laboratories | Medtronic Plc | Boston Scientific Corp | Edwards Lifesciences Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | United States of America |
| City | Danvers | Abbott Park | Dublin | Marlborough | Irvine |
| State/Province | Massachusetts | Illinois | - | Massachusetts | California |
| No. of Employees | - | 115,000 | 95,000 | 59,000 | 15,800 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jeff Caravella | Chief Financial Officer | Senior Management | 2025 | - |
| Will Danzinger | Chief Operating Officer | Senior Management | 2023 | - |
| Navin K. Kapur, M.D. | Chief Medical Officer; Chief Scientific Officer | Senior Management | 2025 | - |
| J. David Stevens | Chief Commercial Officer | Senior Management | 2024 | - |
| Thorsten Siess, Ph.D. | Chief Technology Officer; Managing Director; Executive Vice President | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer